RPS6 and cancer: These results are in a good agreement with the increased DNA damage documented in PanIN lesions of rpS6P-/-;RasG12D vs. RasG12D mice, and support the hypothesis that absence of rpS6 phosphorylation may negate Kras-driven cancer development by enhancing tumor suppressive DNA damage [19].